Clinical Research

Advance Allergy & Asthma Care Through Clinical Trials

We partner with leading researchers and biopharmaceutical sponsors to bring cutting-edge therapies to patients with allergy, asthma, and immunologic conditions. Eligible participants receive study-related care at no cost.

Why Participate in a Clinical Trial?

Early Access to New Therapies

Receive investigational treatments years before they're commercially available.

No-Cost Study Care

All study-related visits, labs, and medication provided at no charge — plus stipend in most studies.

Advance Science

Help develop the next generation of allergy and asthma treatments for everyone.

Currently Enrolling Studies

Open for new participant enrollment.

3 active studies
Phase 3Currently enrolling

Peanut Oral Immunotherapy (OIT) for Children & Adults

Peanut Allergy

Investigating an oral immunotherapy protocol to safely desensitize patients with confirmed peanut allergy.

Age range

Ages 4–55

Duration

12–24 months

Compensation

Travel reimbursement provided

Eligibility Highlights

  • Confirmed peanut allergy via skin prick or specific IgE
  • Reactive to 100mg or less of peanut protein in a controlled challenge
  • No history of severe asthma or eosinophilic GI disorder
Check if I qualify
Phase 2Currently enrolling

Biologic Therapy for Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis

Evaluating a new monoclonal antibody for adults with biopsy-confirmed eosinophilic esophagitis.

Age range

Ages 18–75

Duration

52 weeks

Compensation

Study-related care at no cost + stipend

Eligibility Highlights

  • Biopsy-confirmed EoE (≥15 eos/hpf)
  • Symptomatic on standard PPI therapy
  • No active eosinophilic gastritis or colitis
Check if I qualify
Phase 3Currently enrolling

Novel Therapy for Antihistamine-Resistant Chronic Urticaria

Chronic Spontaneous Urticaria

Testing a next-generation biologic for patients with chronic hives uncontrolled by antihistamines.

Age range

Ages 18–75

Duration

24 weeks

Compensation

Stipend per visit + medication at no cost

Eligibility Highlights

  • Chronic spontaneous urticaria for ≥6 months
  • Inadequate response to second-generation H1 antihistamines
  • UAS7 score ≥16 at screening
Check if I qualify

Coming Soon

Studies opening for enrollment in the coming months. Join the waitlist to be notified.

Phase 3Coming soon

Long-Acting Biologic for Severe Eosinophilic Asthma

Severe Asthma

Investigating a long-acting injectable biologic for adolescents and adults with severe eosinophilic asthma.

How Enrollment Works

Four simple steps from initial inquiry to study participation.

1

Inquire

Contact our research team to discuss studies you might qualify for.

2

Pre-Screen

Brief phone or video call to review your medical history and eligibility.

3

Screening Visit

On-site evaluation with our research physician and informed consent.

4

Enroll

Begin the study with full support from our research coordinators.

Patient Safety First

IRB-Reviewed

Every study is reviewed and approved by an independent Institutional Review Board to protect participant safety.

Informed Consent

You'll receive a complete explanation of risks, benefits, and procedures before agreeing to participate.

Withdraw Anytime

Participation is fully voluntary. You can leave a study at any time without affecting your regular care.

Contact Our Research Team

Interested in participating or have questions about a study? Reach out — there's no obligation to enroll.